Antibiotic deprescribing: Spanish general practitioners' views on a new strategy to reduce inappropriate use of antibiotics in primary care
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Antibiotic deprescribing : Spanish general practitioners' views on a new strategy to reduce inappropriate use of antibiotics in primary care. / Llor, Carl; Cordoba, Gloria; de Oliveira, Sandi Michele; Bjerrum, Lars; Moragas, Ana.
In: The European Journal of General Practice, Vol. 28, No. 1, 12.2022, p. 217-223.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Antibiotic deprescribing
T2 - Spanish general practitioners' views on a new strategy to reduce inappropriate use of antibiotics in primary care
AU - Llor, Carl
AU - Cordoba, Gloria
AU - de Oliveira, Sandi Michele
AU - Bjerrum, Lars
AU - Moragas, Ana
PY - 2022/12
Y1 - 2022/12
N2 - BACKGROUND: A doctor may recommend that a patient stop an antibiotic course before its scheduled completion time if further treatment may cause more harm than benefit.OBJECTIVES: This study explores general practitioners' (GP) opinions about the use of antibiotic deprescribing (AD) in general practice.METHODS: A cross-sectional, questionnaire-based study answered from February to March 2022. GPs (n = 6,083) affiliated with the largest Spanish scientific society of primary care were invited to participate. The survey included two statements related to use and fourteen views about AD rated by GPs using a 5-item Likert scale.RESULTS: Eleven hundred and seven doctors completed the surveys (18.2%), of whom 92.5% (95% confidence interval [CI] 90.8-94%) reported having used the AD strategy in their practice at least once. GPs felt very confident in using a deprescribing strategy in patients with common cold and influenza (97.6% and 93.5%, respectively) but less with acute bronchitis (45.5%); 12.1% (95% CI, 10.2-14.2%) considered this practice harmful to patients. Respondents reported using AD more frequently when they initiated the antibiotic course (96.8%; 95% CI, 95.5-97.7) than when the treatment was initiated by another doctor (52.3%; 95% CI, 49.3-55.3%). However, doctors aged >60 years were more prone to use AD compared with younger colleagues (64.5% vs. 50%; p < 0.005).CONCLUSION: The GPs in this study employ the strategy of AD. Nonetheless, essential differences lie in their views of the way the strategy is used. Further studies are warranted to explore the beliefs behind these perceptions and promote wider use of AD by GPs.
AB - BACKGROUND: A doctor may recommend that a patient stop an antibiotic course before its scheduled completion time if further treatment may cause more harm than benefit.OBJECTIVES: This study explores general practitioners' (GP) opinions about the use of antibiotic deprescribing (AD) in general practice.METHODS: A cross-sectional, questionnaire-based study answered from February to March 2022. GPs (n = 6,083) affiliated with the largest Spanish scientific society of primary care were invited to participate. The survey included two statements related to use and fourteen views about AD rated by GPs using a 5-item Likert scale.RESULTS: Eleven hundred and seven doctors completed the surveys (18.2%), of whom 92.5% (95% confidence interval [CI] 90.8-94%) reported having used the AD strategy in their practice at least once. GPs felt very confident in using a deprescribing strategy in patients with common cold and influenza (97.6% and 93.5%, respectively) but less with acute bronchitis (45.5%); 12.1% (95% CI, 10.2-14.2%) considered this practice harmful to patients. Respondents reported using AD more frequently when they initiated the antibiotic course (96.8%; 95% CI, 95.5-97.7) than when the treatment was initiated by another doctor (52.3%; 95% CI, 49.3-55.3%). However, doctors aged >60 years were more prone to use AD compared with younger colleagues (64.5% vs. 50%; p < 0.005).CONCLUSION: The GPs in this study employ the strategy of AD. Nonetheless, essential differences lie in their views of the way the strategy is used. Further studies are warranted to explore the beliefs behind these perceptions and promote wider use of AD by GPs.
KW - Humans
KW - General Practitioners
KW - Anti-Bacterial Agents/adverse effects
KW - Deprescriptions
KW - Cross-Sectional Studies
KW - Surveys and Questionnaires
KW - Primary Health Care
KW - Attitude of Health Personnel
U2 - 10.1080/13814788.2022.2130887
DO - 10.1080/13814788.2022.2130887
M3 - Journal article
C2 - 36314609
VL - 28
SP - 217
EP - 223
JO - European Journal of General Practice
JF - European Journal of General Practice
SN - 1381-4788
IS - 1
ER -
ID: 324526525